The Kiwi cervical cancer screening device company made a mistake with allotting shares under its SPP.
Retail trading platforms forced to cut staff, raise fees in recent months, as winds of recession start to strengthen.
BioViros’s new lab will produce lentiviral vectors for cell and gene therapy.
It will use the funds to do a demo unit and commercial pilot in the US oil and gas industry.
Simon Malpas’s Kitea Health will use seed round for first in-human clinical trial.
VC fund Blackbird appoints first partners since 2018.
‘We're five million people, one small city by US standards. We have to work together’ says Peter Hunter.
‘There isn’t enough help in the market at the moment,’ CEO says.
Latest tech salary guide shows some salaries in the local market are up as much as 46% year-on-year.
Local manufacturer Ohmio was confirmed as one of 24 recipients in the first round of Waka Kotahi's Hoe ki angitū-Innovation Fund.
